Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/18/2026

1. NFLX
2. ISRG
3. SPY
4. AAPL
5. USB
6. NVDA
7. CFG
8. STT
9. SPCX
10. BA

Go back to Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer
(NASDAQ: LXEO) Delayed: 4.69 +0.13 (2.85%)
Previous Close $4.56    52 Week High $ 
Open $4.47    52 Week Low $ 
Day High $4.75    P/E N/A 
Day Low $4.47    EPS $ 
Volume 730,135